{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:26:18Z","timestamp":1794327978182,"version":"4.9.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Prognostication in chronic myelomonocytic leukemia (CMML) remains a challenge because of the biological complexity and variable clinical course of the disease. This study aimed to evaluate the prognostic utility of the Molecular International Prognostic Scoring System (IPSS-M) in CMML and its applicability across the myelodysplastic (MD) and myeloproliferative (MP) subsets of the disease. We conducted a multicenter, retrospective study including 511 patients diagnosed with CMML. Clinical, cytogenetic, and molecular data were collected at diagnosis, including targeted next-generation sequencing. Patients were stratified using IPSS-M, the molecular CMML-specific prognostic scoring system (CPSS-Mol), and the recently developed international CPSS (iCPSS). IPSS-M effectively stratified patients into risk groups with significantly different overall survival (OS) and cumulative incidence of acute myeloid leukemia (AML) progression. Discrimination was maintained after merging overlapping intermediate-risk categories, yielding a 4-tier model with a C-index of 0.678 for OS and 0.628 for AML progression, respectively. This model retained its prognostic performance in both MD-CMML and MP-CMML subsets, with a higher discrimination for OS in the MD-CMML group. When compared with CPSS-Mol and iCPSS, adapted IPSS-M showed comparable prognostic performance to iCPSS and improved discrimination compared with CPSS-Mol. These findings support the applicability of an adapted IPSS-M to CMML, extending its use beyond myelodysplastic syndromes and highlighting its potential utility in guiding clinical decision-making and therapeutic strategies. Moreover, this study provides an external validation of the iCPSS in an independent and genetically well-characterized CMML cohort, reinforcing its clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019760","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:24:02Z","timestamp":1785457442000},"page":"7255-7263","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the IPSS-M in chronic myelomonocytic leukemia"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-6271","authenticated-orcid":false,"given":"Laura","family":"Palomo","sequence":"first","affiliation":[{"name":"1Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia, Josep Carreras, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-2534","authenticated-orcid":false,"given":"Mireia","family":"Morgades","sequence":"additional","affiliation":[{"name":"1Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia, Josep Carreras, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Meggendorfer","sequence":"additional","affiliation":[{"name":"2Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"D\u00edaz-Bey\u00e1","sequence":"additional","affiliation":[{"name":"3Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-5682","authenticated-orcid":false,"given":"Helena","family":"Pomares","sequence":"additional","affiliation":[{"name":"4Institut Catal\u00e0 d\u2019Oncologia, Hospital Duran i Reynals, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Francisco","family":"Falantes","sequence":"additional","affiliation":[{"name":"5Hospital V\u00edrgen del Roc\u00edo de Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0287-6967","authenticated-orcid":false,"given":"Guillermo","family":"Ramil","sequence":"additional","affiliation":[{"name":"6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Iba\u00f1ez","sequence":"additional","affiliation":[{"name":"7Hospital General Universitario de Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tormo","sequence":"additional","affiliation":[{"name":"8Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"L\u00f3pez-Cadenas","sequence":"additional","affiliation":[{"name":"9Hospital Universitario Vall d\u2019Hebr\u00f3n, Institut d\u2019Oncologia Vall d\u2019Hebr\u00f3n, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Avenda\u00f1o","sequence":"additional","affiliation":[{"name":"10Hospital Cl\u00ednico Universitario de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Caballero-Berrocal","sequence":"additional","affiliation":[{"name":"11Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-513X","authenticated-orcid":false,"given":"Teresa","family":"Bernal","sequence":"additional","affiliation":[{"name":"12Hospital Universitario Central de Asturias, Asturias, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[{"name":"13Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8874-2622","authenticated-orcid":false,"given":"Juan","family":"Restrepo","sequence":"additional","affiliation":[{"name":"14Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Roldan","sequence":"additional","affiliation":[{"name":"15Hospital Universitario de Cruces, Baracaldo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9993-6857","authenticated-orcid":false,"given":"Pilar","family":"Galan","sequence":"additional","affiliation":[{"name":"16Complejo Asistencial de Segovia, Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Cerezo","sequence":"additional","affiliation":[{"name":"17El Consorci Sanitari de Terrassa, Hospital Universitari, Terrassa, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Notario","sequence":"additional","affiliation":[{"name":"18Hospital Universitario Nuestra Se\u00f1ora de Candelaria, Santa Cruz de Tenerife, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garc\u00eda-Feria","sequence":"additional","affiliation":[{"name":"19Hospital Universitario Doctor Peset, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-8829","authenticated-orcid":false,"given":"Luca","family":"Lanino","sequence":"additional","affiliation":[{"name":"20Humanitas Clinical and Research Center, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"2Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9044-4665","authenticated-orcid":false,"given":"Sandra","family":"Casta\u00f1o-D\u00edez","sequence":"additional","affiliation":[{"name":"3Hospital Clinic de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Alonso","sequence":"additional","affiliation":[{"name":"21Hospital Universitari de Bellvitge, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6375-596X","authenticated-orcid":false,"given":"Marta","family":"Pratcorona","sequence":"additional","affiliation":[{"name":"6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-6192","authenticated-orcid":false,"given":"Rosa","family":"Collado","sequence":"additional","affiliation":[{"name":"7Hospital General Universitario de Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-820X","authenticated-orcid":false,"given":"Marisa","family":"Calabuig","sequence":"additional","affiliation":[{"name":"8Hospital Cl\u00ednico Universitario de Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Acha","sequence":"additional","affiliation":[{"name":"9Hospital Universitario Vall d\u2019Hebr\u00f3n, Institut d\u2019Oncologia Vall d\u2019Hebr\u00f3n, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Del Rey","sequence":"additional","affiliation":[{"name":"10Hospital Cl\u00ednico Universitario de Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0767-9172","authenticated-orcid":false,"given":"Gerardo","family":"Aguilar","sequence":"additional","affiliation":[{"name":"11Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Loredo","sequence":"additional","affiliation":[{"name":"12Hospital Universitario Central de Asturias, Asturias, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-5970","authenticated-orcid":false,"given":"Matteo","family":"Della Porta","sequence":"additional","affiliation":[{"name":"20Humanitas Clinical and Research Center, IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5122-7481","authenticated-orcid":false,"given":"Marta","family":"Cabez\u00f3n","sequence":"additional","affiliation":[{"name":"1Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia, Josep Carreras, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7823-2088","authenticated-orcid":false,"given":"Neus","family":"Ruiz-Xivill\u00e9","sequence":"additional","affiliation":[{"name":"1Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia, Josep Carreras, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-7110","authenticated-orcid":false,"given":"Lurdes","family":"Zamora","sequence":"additional","affiliation":[{"name":"1Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia, Josep Carreras, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0295-1307","authenticated-orcid":false,"given":"Blanca","family":"Xicoy","sequence":"additional","affiliation":[{"name":"1Institut Catal\u00e0 d\u2019Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leuc\u00e8mia, Josep Carreras, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,29]]},"reference":[{"issue":"7","key":"2026111011022916200_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"2026111011022916200_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2141.1994.tb06734.x","article-title":"Proposals by the French-American-British Cooperative Leukaemia Group","volume":"87","author":"Bennett","year":"1994","journal-title":"Br J Haematol"},{"issue":"10","key":"2026111011022916200_bib3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"},{"issue":"17","key":"2026111011022916200_bib4","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1200\/JCO-25-02116","article-title":"A molecular-based ecosystem to improve personalized medicine in chronic myelomonocytic leukemia","volume":"44","author":"Lanino","year":"2026","journal-title":"J Clin Oncol"},{"issue":"7","key":"2026111011022916200_bib5","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"19","key":"2026111011022916200_bib6","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J Clin Oncol"},{"issue":"16","key":"2026111011022916200_bib7","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood.2019004229","article-title":"Molecular landscape and clonal architecture of adult myelodysplastic\/myeloproliferative neoplasms","volume":"136","author":"Palomo","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2026111011022916200_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2010.030957","article-title":"Cytogenetic risk stratification in chronic myelomonocytic leukemia","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"key":"2026111011022916200_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ebiom.2018.04.018","article-title":"Prognostic role of gene mutations in chronic myelomonocytic leukemia patients treated with hypomethylating agents","volume":"31","author":"Duchmann","year":"2018","journal-title":"EBioMedicine"},{"issue":"7","key":"2026111011022916200_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ajh.25488","article-title":"Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients","volume":"94","author":"Coston","year":"2019","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7255\/2597418\/blooda_adv-2026-019760-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7255\/2597418\/blooda_adv-2026-019760-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:02:32Z","timestamp":1794326552000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/21\/7255\/569983\/Assessment-of-the-IPSS-M-in-chronic-myelomonocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,29]]},"references-count":10,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,11,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019760","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,10]]},"published":{"date-parts":[[2026,10,29]]}}}